×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors
PR Newswire
Share this article ... BETHESDA, Md., March 21, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company...
1 month ago
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units ...
PR Newswire
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and...
2 months ago
Northwest Bio: Is There Ever Going To Be A Right Time? (OTCMKTS:NWBO)
Seeking Alpha
"NWBO has one huge strength working in its favor: positive phase 3 results." LOL, nah. Do the slightest bit of diligence as to what actually...
8 months ago
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Yahoo Finance
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...
5 months ago
'Spoofing' case might draw back curtain on high-speed trading firms
Financial Times
Seven broker-dealers including Citadel Securities face a challenge from a cancer vaccine company.
2 months ago
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK ...
PR Newswire
The MAA seeks approval for commercialization of DCVax-L for both newly diagnosed and recurrent glioblastoma (GBM). The application also requests...
4 months ago
Chancery Refuses Toss Of Biotech Firm Share Award Suit
Law360
Unjust enrichment and fiduciary breach claims against six directors or officers of biotech venture Northwest Biotherapeutics moved toward...
5 months ago
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application
Yahoo Finance
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...
6 months ago
Northwest Bio: Another Small Filing Delay (OTCMKTS:NWBO)
Seeking Alpha
There is considerable bias built into NWBO's trial and questionable that the FDA would accept the data. Notice, NWBO has NOT filed an...
6 months ago
Northwest Bio study of brain cancer vaccine still falls short
www.statnews.com
Northwest Bio study of brain cancer vaccine still falls short ... Northwest Biotherapeutics tried again, but its experimental treatment for brain...
17 months ago